Access brought to you by: LOCKSS

Diabetes & Metabolic Syndrome

Novel Pharmacotherapies in the Treatment of Diabetic Retinopathy
Participation in VA's MOVE! Associated with Weight Loss
Novel Targets in Insulin Resistance and Type 2 Diabetes
Neurocognitive Decline Unrelated to Mild Cognitive Impairment in Type 1 Diabetes
Cellular-Based Strategies, Closed-Loop Algorithms Are Latest Developments in Therapy for Type 1 Diabetes
Metformin/Pioglitazone/Exenatide Triple Therapy Superior to Stepwise Add-On Conventional Therapy in Newly Diagnosed Type 2 Diabetes
Carbohydrate Counting Does Not Improve Glycemic Control in Type 1 Diabetes Patients
Insulin Dose Not Linked to Cardiovascular Mortality in the ACCORD Trial
Lifestyle Intervention is Beneficial in Pregnant Women at Risk for Gestational Diabetes

Pages